Respiratory tract infections in the immunocompromised

Current Opinion in Pulmonary Medicine

Volumn 19, Issue 3, 2013, Pages 244-250

  Godbole, Gauri ^a,b   Gant, Vanya ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b NORTH MIDDLESEX UNIVERSITY HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

Antifungals; Bone marrow transplant; HIV; Immunosuppressed; Pulmonary infections; Solid organ transplant

Indexed keywords

AMPHOTERICIN B; FLUCYTOSINE; OSELTAMIVIR; RIBAVIRIN; ZANAMIVIR;

ACINETOBACTER; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADAPTIVE IMMUNITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BONE MARROW TRANSPLANTATION; CELLULAR IMMUNITY; CHEMOPROPHYLAXIS; CHLAMYDIA; CHRYSEOBACTERIUM; COMMUNITY ACQUIRED PNEUMONIA; CYTOMEGALOVIRUS; ENTEROBACTERIACEAE; HAEMOPHILUS; HEMATOPOIETIC STEM CELL; HUMAN; HUMORAL IMMUNITY; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA A; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA A (H5N1); INFLUENZA B; INNATE IMMUNITY; LEGIONELLA; LOWER RESPIRATORY TRACT INFECTION; LUNG TUBERCULOSIS; MORAXELLA CATARRHALIS; MORTALITY; MULTIPLEX POLYMERASE CHAIN REACTION; MYCOPLASMA; NONHUMAN; PARAINFLUENZA VIRUS INFECTION; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PSEUDOMONADACEAE; RAPID TEST; RESPIRATORY TRACT INFECTION; REVIEW; SPHINGOMONAS; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS PNEUMONIAE; UPPER RESPIRATORY TRACT INFECTION;

AGE FACTORS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; IMMUNOCOMPROMISED HOST; RESPIRATORY TRACT INFECTIONS; VIRUS DISEASES;

EID: 84878100233     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32835f82a9     Document Type: Review

References (68)

1. Kay HE. Infection of immunosuppressed patients. Clin Pathol Suppl (R Coll Pathol) 1979; 13:26-29.
2. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007; 357:2601-2614.
3. Corti M, Palmer D, Eiguchi K. Respiratory infections in immunocompromised patients. Curr Opin Pulmon Med 2009; 15:209-217.
4. Sanders KM, Marras TK, Chan CK. Pneumonia severity index in the immunocompromised. Can Respir J 2006; 13:89-93.
5. Engelhart S, Krizek L, Glasmacher A, et al. Pseudomonas aeruginosa outbreak in a haematology-oncology unit associated with contaminated surface cleaning equipment. J Hosp Infect 2002; 52:93-98.
6. Küpeli E, Eyüboglu FO, Haberal M. Pulmonary infections in transplant recipients. Curr Opin Pulmon Med 2012; 18:202-212.
7. Samonis G, Karageorgopoulos DE, Maraki S, et al. Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome. PLoS One 2012; 7:e37375.
8. Brooke JS. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev 2012; 25:2-41.
9. Chen FL, Wang GC, Teng SO, et al. Clinical and epidemiological features of Chryseobacterium indologenes infections: analysis of 215 cases. J Microbiol Immunol Infect 2012. doi: 10.1016/j.jmii.2012.08.007. [Epub ahead of print]
10. Struelens MJ, Monnet DL, Magiorakos AP, et al. New Delhi metallo-betalactamase 1-producing Enterobacteriaceae: emergence and response in Europe. Euro Surveill 2010; 15:ii19716.
11. Torres A, Ewig S, Lode H, Carlet J, for the European HAP Working Group. Defining, treating and preventing hospital acquired pneumonia: European perspective. Intensive Care Med 2009; 35:1336-1339.
12. Dortet L, Poirel L, Anguel N, Nordmann P. New Delhi metallo-b-lactamase 4-producing Escherichia coli in Cameroon [letter]. Emerg Infect Dis 2012; 18:1540-1542.
13. Dortet L, Nordmann P, Poirel L. Association of the emerging carbapenemase NDM-1 with a bleomycin resistance protein in Enterobacteriaceae and Acinetobacter baumannii. Antimicrob Agents Chemother 2012; 56:1693-1697.
14. Paterson, David L. The epidemiological profile of infections with multidrugresistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis 2006; 43(Suppl 2):S43-S48.
15. Gudiol C, Garcia-Vidal C, Fernandez-Sabe N, et al. Clinical features and outcomes of Legionnaires' disease in solid organ transplant recipients. Transpl Infect Dis 2009; 11:78-82.
16. Blasi F, Ostermann H, Medina J, et al. Current management of patients hospitalised with community-acquired pneumonia across Europe (2010-2011): assessment of clinical practice patterns and real-life effectiveness of antibiotics (REACH study) [abstract]. In: 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 31 March-3 April 2012, London, UK. The European Society of Clinical Microbiology and Infectious Diseases. 2012.
17. Shannon VR, Andersson BS, Lei X, et al. Utility of early versus late fiberoptic bronchoscopy in the evaluation of new pulmonary infiltrates following hematopoietic stem cell transplantation. Bone Marrow Transplant 2010; 45:647-655.
18. Frederick S. Nolte. Molecular diagnostics for detection of bacterial and viral pathogens in community-acquired pneumonia. Clin Infect Dis 2008; 47 (Suppl 3):S123-S126.
19. Collaboration between macrophages and vaccine-induced CD4 T cells confers protection against lethal Pseudomonas aeruginosa pneumonia during neutropenia. J Infect Dis 2013; 207:39-49.
20. Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease. Thorax 2010; 65:559-570.
21. Vachharajani T, Abreo K, Phadke A, et al. Diagnosis and treatment of tuberculosis in hemodialysis and renal transplant patients. Am J Nephrol 2000; 20:273-277.
22. Lopez de Castilla D, Schluger NW. Tuberculosis following solid organ transplantation. Transpl Infect Dis 2010; 12:106-112.
23. Yao C, Zhu T, Li Y, et al. Detection of rpoB, katG and inhA gene mutations in Mycobacterium tuberculosis clinical isolates from Chongqing as determined by microarray. Clin Microbiol Infect 2010; 16:1639-1643.
24. Dixon WG, Hyrich KL, Watson KD, et al. Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR). Ann Rheum Dis 2010; 69:522-528.
25. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175:367-416.
26. Dorman S, Subramanian A. AST Infectious Diseases Community of Practice. Nontuberculous mycobacteria in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl 4):S63-S69.
27. Patel R, Roberts GD, Keating MR, Paya CV. Infections due to nontuberculous mycobacteria in kidney, heart, and liver transplant recipients. Clin Infect Dis 1994; 19:263-273.
28. Harris KA, Kenna DT, Blauwendraat C, et al. Molecular fingerprinting of Mycobacterium abscessus strains in a cohort of pediatric cystic fibrosis patients. J Clin Microbiol 2012; 50:1758-1761.
29. Englund J, Feuchtinger T, Ljungman P. Viral infections in immunocompromised patients. Biol Blood Marrow Transplant 2011; 17 (1 Suppl):S2-S5.
30. Protheroe RE, Kirkland KE, Pearce RM. The clinical features and outcome of 2009 H1N1 influenza infection in allo-SCT patients: a British Society of Blood and Marrow Transplantation study. Bone Marrow Transplant 2012; 47: 88-94.
31. Gainer SM, Patel SJ, Seethamraju H, et al. Increased mortality of solid organ transplant recipients with H1N1 infection: a single center experience. Clin Transplant 2012; 26:229-237.
32. Cordero E, Aydillo T, Fariñas MC, et al. Immunosuppressed patients with pandemic influenza A 2009 (H1N1) virus infection. Eur J Clin Microbiol Infect Dis 2012; 31:547-556.
33. Hodson A, Kasliwal M, Streetly M, et al. A parainfluenza-3 outbreak in a SCT unit: sepsis with multiorgan failure and multiple co-pathogens are associated with increased mortality. Bone Marrow Transplant 2011; 46:1545-1550.
34. Louis JK, Acosta M, Jamieson DJ, et al. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med 2009; 374: 451-458.
35. Schildgen V, van den Hoogen B, Fouchier R, et al. Human metapneumovirus: lessons learned over the first decade. Clin Microbiol Rev 2011; 24734- 24754.
36. Kidd MI, Down J, Nastouli E. H1N1 pneumonitis treated with intravenous zanamivir. Lancet 2009; 374:1036.
37. Daniel E, Dulek DE, Williams JV, et al. Use of intravenous zanamivir after development of oseltamivir resistance in a critically ill immunosuppressed child infected with 2009 pandemic influenza A (H1N1) virus. Clin Infect Dis 2010; 50:1493-1496.
38. Harvala H, Gunson R, Simmonds P, et al. The emergence of oseltamivirresistant pandemic influenza A (H1N1) 2009 virus amongst hospitalised immunocompromised patients in Scotland, November-December, 2009. Euro Surveill 2010; 15.
39. Tramontana AR, George B, Hurt AC, et al. Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia. Emerg Infect Dis 2010; 16:1068-1075.
40. Green Book, 2006 Edition. Department of Health UK, Updated 2012. Chapter 19 http://immunisation.dh.gov.uk/green-book-chapters/chapter-19/. Latest guidance on influenza vaccination from HPA, UK.
41. Schenk T, Strahm B, Kontny U, et al. Disseminated bocavirus infection after stem cell transplant. Emerg Infect Dis 2007; 13:1425-1427.
42. Bermingham A, Chand MA, CS Brown CS, et al. Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012; Euro Surveill 17:40.
43. Ljungman P. CMV infections after hematopoietic stem cell transplantation. Bone Marrow Transplant 2008; 42 (Suppl 1):S70-S72.
44. Boeckh M, Boivin G. Quantitation of cytomegalovirus: methodologic aspects and clinical applications. Clin Microbiol Rev 1998; 11:533- 554.
45. Morris A. Is there anything new in Pneumocystis jirovecii pneumonia? Changes in P. jiroveci pneumonia over the course of the AIDS epidemic. Clin Infect Dis 2008; 46:634-636.
46. Overgaard UM, Helweg-Larsen J. Pneumocystis jiroveci pneumonia (PCP) in HIV-1-negative patients: a retrospective study. Scand J Infect Dis 2007; 39:589-595.
47. Torres HA, Chemaly RF, Storey R, et al. Influence of type of cancer and hematopoietic stem cell transplantation on clinical presentation of Pneumocystis jiroveci pneumonia in cancer patients. Eur J Clin Microbiol Infect Dis 2006; 25:382-388.
48. De Boer MG, Kroon FP, le Cessie S, et al. Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis. Transpl Infect Dis 2011; 13:559-569.
49. Torres J, Goldman M, Joseph Wheat L, et al. Diagnosis of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients with polymerase chain reaction: a blinded comparison to standard methods. Clin Infect Dis 2000; 30:141-145.
50. Singh N, Dromer F, Perfect JR, et al. Cryptococcosis in solid organ transplant recipients: current state of the science. Clin Infect Dis 2008; 47:1321-1327.
51. Aberg JA, Mundy LM, Powderly WG. Pulmonary cryptococcosis in patients without HIV infection. Chest J 1999; 115:734-740.
52. Saag MS, Graybill RJ, Larsen RA, et al. Practice guidelines for the management of cryptococcal disease. Clin Infect Dis 2000; 30:710-718.
53. Pappas PG, Alexander BD, Andes DR, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 2010; 50:1101-1111.
54. Hoenigl M, Strenger V, Buzina W, et al. European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies. J Antimicrob Chemother 2012; 67:2029-2033.
55. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46:1813-1821.
56. Verdaguer V, Walsh TJ, Hope W, et al. Galactomannan antigen detection in the diagnosis of invasive aspergillosis. Expert Rev Mol Diagn 2007; 7:21-32.
57. Nguyen MH, Leather H, Clancy CJ, et al. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients. Biol Blood Marrow Transplant 2011; 17:1043-1050.
58. Clancy CJ, Jaber RA, Leather HL, et al. Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients. J Clin Microbiol 2007; 45:1759-1765.
59. Zou M, Tang L, Zhao S, et al. Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis. PLoS ONE 2012; 7:e43347.
60. Tuon FF. A systematic literature review on the diagnosis of invasive aspergillosis using polymerase chain reaction (PCR) from bronchoalveolar lavage clinical samples. Rev Iberian Micol 2007; 24:89-94.
61. Stanzani M, Battista G, Sassi C, et al. Computed tomographic pulmonary angiography for diagnosis of invasive mold diseases in patients with hematological malignancies. Clin Infect Dis 2012; 54:610-616.
62. Matt P, Bernet F, Habicht J, et al. Predicting outcome after lung resection for invasive pulmonary aspergillosis in patients with neutropenia. Chest 2004; 126:1783-1788.
63. Arthaus M. Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin: review of the literature. Eur J Med Res 2011; 16:145-152.
64. Park BJ, Pappas PG, Wannemuehler KA, et al. Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006. Emerg Infect Dis 2011; 17:1855-1864.
65. Krishnamurthy R, Dincer HE, Whittemore D. Strongyloides stercoralis hyperinfection in a patient with rheumatoid arthritis after anti-TNF-alpha therapy. J Clin Rheumatol 2007; 13:150-152.
66. Fardet L, Générau T, Cabane J, Kettaneh A. Severe strongyloidiasis in corticosteroid-treated patients. Clin Microbiol Infect 2006; 12:945-947.
67. Roxby AC, Gottlieb GS, Limaye AP. Strongyloidiasis in transplant patients. Clin Infect Dis 2009; 49:1411-1423.
68. Kramme S, Nissen N, Soblik H, et al. Novel real-time PCR for the universal detection of Strongyloides species. J Med Microbiol 2011; 60:454-458.